HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf Deftly Defuses Sunscreen, DSHEA Probes In Confirmation Hearing

This article was originally published in The Tan Sheet

Executive Summary

FDA commissioner nominee Robert Califf suggests adequate evidence is key to moving sunscreen TEAs through FDA’s evaluation process during his Senate confirmation hearing. He just as smoothly handled HELP Committee members’ questions about DSEHA and FDA rulemaking.

You may also be interested in...



Sharfstein Suggests Requiring Supplements Registration, Testing Standards

Oversight authorized by DSHEA “is not the regulatory system for dietary supplements sold to the American public,” says former FDA official Joshua Sharfstein.

Fortnite-Branded Cosmetics Roll Out As Gaming And Beauty Merge

Revolution Beauty x Fortnite is the first Fortnite-branded cosmetics and skin-care line, developed through a deal between Epic Games, Inc. and UK-based Revolution Beauty Group Limited. Separately, The Procter & Gamble Co.’s Gillette brand kicks off its second annual Gillette Cup featuring Fortnite.

Ulta Working To Combat Surging Retail Theft As Q1 Sales Rise 12.3%

Ulta Beauty says consumers are being more selective in their spending but show “continued willingness to splurge and treat themselves.” The company is implementing additional mitigation strategies in its stores – including placing fragrances in locked cabinets – to combat organized retail theft that is expected to slightly reduce its operating margins for the full year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel